Barinthus Biotherapeutics (BRNS) Return on Capital Employed Growth (1y) (2022 - 2026)
Barinthus Biotherapeutics (BRNS) Return on Capital Employed Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 68,255.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 2,665.00 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 31,429.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 2,503.00 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 16,829.00 |
| 10 | Barinthus Biotherapeutics | 27.08 Mn | -40.03 Mn | - | -1,590.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,590.00 |
| Dec 31, 2025 | -3,254.00 |
| Sep 30, 2025 | -3,847.00 |
| Jun 30, 2025 | -2,217.00 |
| Mar 31, 2025 | -1,062.00 |
| Dec 31, 2024 | -276.00 |
| Sep 30, 2024 | 316.00 |
| Jun 30, 2024 | -1,300.00 |
| Mar 31, 2024 | -3,059.00 |
| Dec 31, 2023 | -3,851.00 |
| Sep 30, 2023 | -4,223.00 |
| Jun 30, 2023 | -2,411.00 |
| Mar 31, 2023 | 411.00 |
| Dec 31, 2022 | 1,604.00 |
| Sep 30, 2022 | 1,684.00 |
| Jun 30, 2022 | 1,361.00 |
| Mar 31, 2022 | 720.00 |